---
$id: https://graph.org.ai/products/commodity/51141521
$type: Product
source: UNSPSC
code: "51141521"
title: "Mesuximide or methsuximide"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mesuximide or methsuximide

**UNSPSC Code**: 51141521
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C12H13NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 0G76K8X6C0, chemically known as 2,5-pyrrolidinedione,1,3-dimethyl-3-phenyl- but more generally known as mesuximide, which bears US NIH Compound Identifier 6476. European Medicines Agency schedules Mesuximide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08797MIG. The term MESUXIMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules mesuximide in its Anatomical Therapeutic Chemical (ATC) Classification. Methsuximide bears US NLM identifiers UMLS ID C0109002 and NCI Concept Code C47613. MESUXIMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CC1(CC(=O)N(C1=O)C)C2=CC=CC=C2.

